Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

MaxCyte, Inc. (MXCT)

NASDAQ

$1.01

$+0.20

(+24.67%)

MaxCyte, Inc. (MXCT) Live Price Chart

Page last updated: 2026-05-13 17:43:00

Key Market Data

Market Cap	$108.73M
Open	$0.94
High	$17.44
Low	$0.64
Previous Close	$0.82
Price Change	$+0.20
Percentage Change	+24.67%
Volume	6M

MaxCyte, Inc. (MXCT) Stock Price Today

MaxCyte, Inc. (MXCT) is currently trading at $1.02 as of 2026-05-13 17:43:00, reflecting a +24.67% move ($+0.20) from the previous close.

In the short term, the stock has returned +15.16% over the past four weeks. Over the last 12 months, MaxCyte, Inc. has recorded a -53.86% price change, indicating a Weak performance relative to the broader market.

MaxCyte, Inc. (MXCT) 7-Day Stock Price Changes

Over the past seven days, MaxCyte, Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. During this period, the stock moved from its previous closing price of $0.85 to the latest recorded price of $1.02, reflecting an intraday change of +24.67%. Daily movements highlight shifts in trading volume (6,192,543), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, MXCT has delivered a +15.16% return over the past month and a -53.86% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy MaxCyte, Inc. (MXCT)

You can buy and trade MXCT on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for MXCT and Execute Your Trade

Open the trading page, enter MXCT in the search bar, select the amount of MXCT you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is MaxCyte, Inc. (MXCT)?

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

MaxCyte, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	91
Sector	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Website	https://www.maxcyte.com

Frequently Asked Questions (FAQ)

1.What is the current share price of MaxCyte, Inc.?

The latest trading price for MaxCyte, Inc. (Common Stock) is $ 1.02, compared with a previous closing price of $ 0.82. That means the stock has moved +24.67% so far today. Intraday price updates and recent trading activity for MXCT can be tracked on the live chart and quote section on this page.

2.Is MaxCyte, Inc. stock going up or down?

Looking at recent performances, MXCT has returned +15.16% over the past month, -37.73% over the last six months and -53.86% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for MaxCyte, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does MXCT currently sit relative to its 52-week high and low?

In the most recent 52-week period, MaxCyte, Inc. has traded between a low of $ 0.64 and a high of $ 2.40. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether MXCT is currently nearer the top or the bottom of its one-year trading band.

4.How is MaxCyte, Inc. classified by sector and industry?

MaxCyte, Inc. is classified in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. In practice, this means MaxCyte, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing MXCT’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector could influence MaxCyte, Inc.’s performance.

5.Where is MaxCyte, Inc. listed and how large is it by market value?

MaxCyte, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 108.73M, the company is classified as a Small-cap stock. Market cap gives a quick sense of MaxCyte, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does MXCT's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.42 summarises how much profit MaxCyte, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track MaxCyte, Inc.'s financial performance over time?

To follow MaxCyte, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how MXCT is performing and how the market is responding.

8.When is MaxCyte, Inc. expected to report earnings?

MaxCyte, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for MXCT, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in MaxCyte, Inc.'s earnings reports?

MaxCyte, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether MXCT is meeting, beating or missing expectations.

10.How can I stay informed about MaxCyte, Inc.'s results and guidance?

You can stay up to date on MaxCyte, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for MXCT on this page helps you see how new information is being reflected in the stock.

11.Does MaxCyte, Inc. pay a regular cash dividend to its shareholders?

MaxCyte, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor MXCT's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for MXCT?

Based on the latest earnings data, MXCT has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether MaxCyte, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings MaxCyte, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is MaxCyte, Inc.?

MaxCyte, Inc. is a publicly traded company in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is MXCT valued in terms of P/E ratio and EPS?

MaxCyte, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.42. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of MaxCyte, Inc.'s earnings. Comparing MXCT's P/E and EPS to those of other SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

lululemon athletica inc.

LULU

Civista Bancshares, Inc.

CIVB

MetaVia Inc.

MTVA

Monster Beverage Corporation

MNST

Leslie's, Inc.

LESL

Top Gainers

Browse today's leading gainers in the US stock market

Fitness Champs Holdings Limited

FCHL

Velo3D, Inc.

VELO

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MXCT-to-USD Calculator

Amount

MXCT

USD

1 MXCT = 1.014 USD